Company / Gross Margin
VitaNova Life Sciences Corp Gross Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
59.2%
FY2024
5-year range
59.2% / 100.0%
FY2022-FY2024
Trend
-10.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 100.0% to 59.2% over the past 2 years.
Based on SEC 10-K filings.
59.2% in FY2024.
Declined from 100.0% to 59.2% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, gross margin decreased 10.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 59.2% | -10.6% |
| FY2023 | 66.2% | -33.8% |
| FY2022 | 100.0% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026